Published on
August 1, 2019
Last updated on
March 30, 2022
Definition of Drug/Device Combination Products
On 31.05.2019, the NMPA released a notice on the definition of drug/device combination products (No. 28 of 2019). It was announced that the definition of product attributes of combination products is now the responsibility of the NMPA Management Center for Medical Device Standards.
Related News
Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices
Malaysia’s MDA publishes the 7th edition of guidance on medical device labelling, with new e-labelling, e-IFU, and accessibility requirements
April 1, 2026
Vietnam Authorities Step Up Cosmetic Recalls as Enforcement Tightens
Vietnam’s Drug Administration (DAV) is stepping up cosmetic product recalls as post-market surveillance tightens.
April 1, 2026
BPOM Clarifies Indonesia–US Trade Agreement Impact on Pharmaceutical Regulation
BPOM confirms pharmaceutical authorization, GMP oversight, and regulatory authority remain unchanged under the Indonesia–US trade agreement.
April 1, 2026